Cancer BiologybioRxiv
Functional systemic CD4 immunity is a differential factor for clinical responses to PD-L1/PD-1 blockade therapy in lung cancer
M. Zuazo, H. Arasanz, G. Fernandez-Hinojal…·D. Escors
This study identifies functional systemic CD4 immunity as a key predictor of response to PD-L1/PD-1 blockade therapy in lung cancer patients.
DOI 10.15252/emmm.201910293